We are unlocking the healing power of plants to enhance everyday lives.

Glow Lifetech (CSE:GLOW) is an ingredient technology company pushing the boundaries of innovation and performance in natural health.

Our Mission

We are on a mission to revolutionize the effectiveness of natural health to bring plant possibilities to life. By combining nature’s best active compounds with cutting-edge technology, we unlock a step-change in what’s possible in natural health.

Glow is focused on producing high-performance, water-soluble natural ingredients, using our award-winning MyCell® delivery system technology. With our range of proprietary ingredients including vitamins, cannabinoids and botanicals, Glow is powering a new era of more effective, fast-acting, and great tasting functional foods, beverages, supplements, and personal care products.

 

MyCell technology logo

Empowering proactive health for all

Improving human health is at the root of everything we do. We create solutions to help anyone take control of their well-being and proactively live healthier lives.

Amplifying natures capacity to heal

We believe the future of well-being is rooted in nature and our aim is to unleash nature’s full healing potential using modern science.

Science supporting nature

We use the most advanced science and technologies available, but always in partnership with nature. Our cutting-edge technologies enable us to maximize the health benefits of natural compounds.

Rethinking natural health

Natural doesn’t have to mean ineffective. With our advanced technologies, we are creating a new era of effective, affordable, science-based products that redefine what’s possible in natural health.

Our Team

Headshot of COO Tom Gladwell
Tom Gladwell, PhD Chief Operations Officer
Headshot of CMO Rob Carducci
Rob Carducci Chief Executive Officer & Director
Headshot of COO Josh Bald
Josh Bald Chief Financial Officer
Headshot of DOM Brian Diamond
Brian Diamond Director of Manufacturing
Daniel Proska Board of Directors
James Van Staveren Board of Directors

Latest News

  • 12 . 12 . 2024

    Glow Lifetech Announces Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

    Read More
  • 02 . 12 . 2024

    Glow Lifetech Reports 49% Q/Q Revenue Growth, 73% Gross Margins, and Strengthened Balance Sheet in Q3 2024

    Read More
  • 29 . 11 . 2024

    Glow Lifetech Announces Closing of Non-Brokered Private Placement Offering of Units and Debt Settlement

    Read More
  • 05 . 11 . 2024

    Glow Lifetech Announces Non-Brokered Private Placement Offering of Units and Debt Settlement

    Read More

Have more questions about Glow?

Contact us today and our team will be happy to assist you with any other questions you have.

Contact Us